Theapplications of oligonucleotides are vast, even beyond the life science /pharma sector; however, owing to complexities associated with the synthesis andprocessing of these molecules, such operations are usually outsourced tocapable CMOs
RootsAnalysis is pleased to announce the publication of its recent study, titled, “Oligonucleotide Synthesis, Modificationand Purification Services Market:Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030.”
Thereport features an extensive study of the current scenario and future potentialof the custom synthesis, modification and purification services market foroligonucleotides, which are intended for research, diagnostic, and therapeuticapplications. The study includes in-depth analyses, highlighting thecapabilities of service providers engaged in this domain. In addition to otherelements, it includes:
· A detailed review of the current status ofthe market with respect to oligonucleotide manufacturers focused on researchand diagnostic, and therapeutic applications.
· A competitiveness analysis of prominentoligonucleotide manufacturers, featuring insightful pictorial summaries andrepresentations.
· Elaborate profiles of key players that offera diverse range of capabilities for custom synthesis, modification andpurification of oligonucleotides.
· An analysis of the various partnershipspertaining to oligonucleotide manufacturing, which have been established in therecent past.
· An analysis of the various expansioninitiatives undertaken by service providers engaged in this domain.
· A detailed analysis of completed, ongoing andplanned clinical research studies of various oligonucleotide-based drugproducts.
· An estimate of the overall, annual capacityfor manufacturing oligonucleotides based on data reported by industrystakeholders in the public domain.
· An informed estimate of the annual clinicaland commercial demand for oligonucleotides.
· A discussion on affiliated trends, keydrivers and challenges, under an elaborate SWOT framework.
· A survey analysis featuring inputs solicitedfrom various experts who are directly / indirectly involved in providing customsynthesis, modification and purification services for oligonucleotides.
Requestfor Customization: https://www.rootsanalysis.com/reports/304/request-customization.html
Adetailed market forecast, featuring analysis of the current and projectedfuture opportunity across key market segments (listed below)
Typeof Manufacturing
· Custom Manufacturing
· Large-scale Manufacturing
Typeof Oligonucleotides Manufactured
· Antisense Oligonucleotides
· miRNAs
· shRNAs
· siRNAs
· Other Oligonucleotides
Scaleof Operation
· Clinical
· Commercial
Purposeof Production
· In-house
· Outsourced
TargetTherapeutic Area
· Autoimmune Disorders
· Cardiovascular Disorders
· Genetic Disorders
· Infectious Diseases
· Metabolic Disorders
· Neuromuscular Disorders
· Oncological Disorders
· Ophthalmic Disorders
· Other Therapeutic Areas
Sizeof manufacturer
· Small
· Mid-sized
· Large
KeyGeographical Region
· North America
· Europe
· Asia-Pacific and Rest of the World
Transcriptsof interviews held with the following senior level representatives ofstakeholder companies
· Joachim Bertram (Chief Scientific Officer andManaging Director, IBA Lifesciences)
· Tobias Pohlmann (Founder and ManagingDirector, BianoScience)
Keycompanies covered in the report
· Agilent Technologies
· Ajinomoto Bio-Pharma Services
· BioSpring
· CordenPharma
· Integrated DNA Technologies
· Kaneka Eurogentec
· LGC Biosearch Technologies
· Microsynth
· Nitto Denko Avecia
· Sigma Aldrich
· Thermo Fisher Scientific
· Trilink Biotechnologies
KeyQuestions Answered
· Who are the leading manufacturers ofoligonucleotides for use in research, diagnostic and therapeutic applications?
· What are the preferred custom synthesis,modification and purification methods used for oligonucleotides?
· What are the key challenges faced byoligonucleotide manufacturers?
· What kind of partnership models are commonlyadopted by industry stakeholders?
· What are the recent expansion initiativesundertaken by service providers within this domain?
· What is the annual clinical and commercialdemand for oligonucleotides?
· What is the current, installed manufacturingcapacity for oligonucleotides?
· What percentage of oligonucleotidemanufacturing operations are outsourced to service providers?
· What are the opportunities in emergingmarkets for oligonucleotide manufacturing?
· How is the current and future marketopportunity likely to be distributed across key market segments?
· What are the anticipated future trendsrelated to oligonucleotide manufacturing?
Formore information, please click on the following link:
https://www.rootsanalysis.com/reports/304/request-sample.html
ChapterOutlines
Chapter1is an executive summary of the key insights captured in our research. It offersa high-level view on the likely evolution of the oligonucleotide synthesis,modification and purification services market in the mid to long term.
Chapter2presents a general introduction to oligonucleotides, featuring information onthe oligonucleotide-based products available in the market. Further, itfeatures a detailed discussion on different steps involved in the customsynthesis, chemical modification and purification of oligonucleotides, alongwith information on the key challenges that are currently associated with thismarket. In addition, the chapter includes a brief discussion on the need foroutsourcing within the oligonucleotides market. Further, it includes a list ofcommonly outsourced oligonucleotide synthesis, modification and purificationoperations, and highlights the key factors that need to be considered whileselecting a service provider. The chapter concludes with a discussion on thekey growth drivers and roadblocks related to oligonucleotide manufacturing, aswell as upcoming trends in this field.
Chapter3provides a detailed review of the current status of the market with respect tooligonucleotide manufacturers focused on research and diagnostic applications.The chapter features information on the year of establishment, company size,scale of operation (small, medium, and large), location of headquarters, numberof manufacturing facilities, along with their locations (country-wise), andregulatory accreditations and certifications received by them, type ofoligonucleotide manufactured (antisense oligonucleotides, aptamers, decoys,miRNA, shRNA, siRNA, specialty amidites, and others), type of offering (customsynthesis, modification and purification), type of manufacturing service(s)offered (process development and characterization, method validation andtesting, analytical development, sequencing capabilities, stability studies,quality assurance and control, scale-up, fill/finish, downstream processing,regulatory support, data analytics and reporting, and others), type ofmodification(s) offered (amino modifiers, backbone modifications, fluorescentprobes, dyes and quenchers, modified bases, phosphorylation, thiolmodifications, and others), type of purification method(s) used (desalting,cartridge purification, HPLC, ion exchange purification, PAGE, and others), andcompliance to cGMP standards.
AboutRoots Analysis
RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
ContactInformation
RootsAnalysis Private Limited
GauravChaudhary
+1(415) 800 3415
Gaurav.Chaudhary@rootsanalysis.com
AlsoVisit Our Latest Publication:
Cell Therapy Manufacturing Market Size,2030
Biologics Fill / Finish Services MarketSize, 2030
Vaccine Contract Manufacturing Market Size,2030
mRNA Therapeutics and Vaccines Market Size,2030
Viral Vectors, Non-Viral Vectors and GeneTherapy Manufacturing Market
